PortfoliosLab logoPortfoliosLab logo
ISIN
US45688C1071
CUSIP
45688C107
IPO Date
May 2, 2016

Highlights

Market Cap
$2.62B
Enterprise Value
$4.93B
EPS (TTM)
-$3.52
Total Revenue (TTM)
$1.21B
Gross Profit (TTM)
$476.00M
EBITDA (TTM)
-$28.30M
Year Range
$39.74 - $79.29
Target Price
$76.67
ROA (TTM)
-7.74%
ROE (TTM)
-328.53%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ingevity Corporation

Performance

NGVT Performance Chart

Ingevity Corporation (NGVT) is up 22.9% since the beginning of the year. At $73 per share, NGVT is trading 8.3% below its 52-week high of $79. Investors who bought $1,000 worth of NGVT shares 5 years ago would now be looking at an investment worth $892.


Loading charts...

S&P 500 Index

Returns By Period

Ingevity Corporation (NGVT) has returned 22.91% so far this year and 76.08% over the past 12 months. Over the last ten years, NGVT has returned 7.84% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Ingevity Corporation

1D
-0.91%
1M
9.10%
YTD
22.91%
6M
21.70%
1Y
76.08%
3Y*
11.90%
5Y*
-2.25%
10Y*
7.84%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NGVT Monthly Returns History

Based on dividend-adjusted daily data since May 2, 2016, NGVT's average daily return is +0.09%, while the average monthly return is +1.87%. At this rate, an investment would double in approximately 3.1 years.

Historically, 56% of months were positive and 44% were negative. The best month was Apr 2020 with a return of +47.5%, while the worst month was May 2023 at -34.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, NGVT closed higher 50% of trading days. The best single day was Aug 5, 2025 with a return of +21.3%, while the worst single day was Mar 9, 2020 at -19.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202611.17%9.48%-1.11%6.96%-10.99%7.25%22.91%
202511.29%5.09%-16.93%-16.70%25.44%4.16%-3.02%39.70%-5.46%-2.66%-2.77%13.31%45.23%
2024-7.75%4.87%4.42%7.21%-4.48%-10.52%4.99%-13.86%-1.34%7.15%16.22%-16.10%-13.70%
202317.04%0.15%-13.37%0.31%-34.22%23.25%10.08%-15.82%-11.65%-15.40%-3.70%21.73%-32.96%
2022-8.08%3.52%-6.10%-6.51%16.33%-9.39%6.27%4.53%-13.56%10.95%16.35%-10.00%-1.76%
2021-13.26%5.77%8.71%3.38%5.42%-1.15%4.40%-5.36%-11.22%9.16%-7.70%-0.29%-5.32%

Benchmark Metrics

Ingevity Corporation has an annualized alpha of 3.17%, beta of 1.28, and R2 of 0.27 versus S&P 500 Index. Calculated based on daily prices since May 02, 2016.

  • This stock captured 157.32% of S&P 500 Index gains and 155.20% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.27 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
3.17%
Beta
1.28
0.27
Upside Capture
157.32%
Downside Capture
155.20%

Return for Risk

Risk / Return Rank

NGVT ranks 85 for risk / return — in the top 85% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


NGVT Risk / Return Rank: 8585
Overall Rank
NGVT Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
NGVT Sortino Ratio Rank: 8383
Sortino Ratio Rank
NGVT Omega Ratio Rank: 8383
Omega Ratio Rank
NGVT Calmar Ratio Rank: 8484
Calmar Ratio Rank
NGVT Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Ingevity Corporation (NGVT) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NGVTBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-0.22

Sortino ratioReturn per unit of downside risk

-0.23

Omega ratioGain probability vs. loss probability

1.33

1.37

-0.04

Calmar ratioReturn relative to maximum drawdown

3.19

2.78

+0.41

Martin ratioReturn relative to average drawdown

8.62

12.44

-3.82

Dividends

Dividend History


Ingevity Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ingevity Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ingevity Corporation was 76.22%, occurring on Mar 18, 2020. The portfolio has not yet recovered.

The current Ingevity Corporation drawdown is 37.87%.


Related event

Drawdown

Fall

Recovery

Underwater

COVID crash2020
-76.22%Mar 2020
1y 26d
7y 4moFeb 2019 - now
Rate-hike selloffLate 2018
-28.04%Dec 2018
3mo 1d1mo 22d
4mo 23dSep 2018 - Feb 2019
2017 correction2017
-17.20%Jun 2017
2mo3mo 7d
5mo 7dApr 2017 - Oct 2017
2016 correction2016
-14.95%Nov 2016
1mo 7d9d
1mo 16dSep 2016 - Nov 2016
2018 correction2018
-13.13%Feb 2018
2mo 9d15d
2mo 24dDec 2017 - Feb 2018

Drawdown Indicators


NGVTBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-76.22%

-56.78%

-19.44%

Max Drawdown (1Y)

Largest decline over 1 year

-23.94%

-9.10%

-14.84%

Max Drawdown (3Y)

Largest decline over 3 years

-53.54%

-18.90%

-34.64%

Max Drawdown (5Y)

Largest decline over 5 years

-67.07%

-25.43%

-41.64%

Max Drawdown (10Y)

Largest decline over 10 years

-76.22%

-33.92%

-42.30%

Current Drawdown

Current decline from peak

-37.87%

-1.80%

-36.07%

Average Drawdown

Average peak-to-trough decline

-34.63%

-10.71%

-23.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.85%

2.03%

+6.82%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ingevity Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Ingevity Corporation is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NGVT relative to other companies in the Specialty Chemicals industry. Currently, NGVT has a P/S ratio of 2.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NGVT in comparison with other companies in the Specialty Chemicals industry. Currently, NGVT has a P/B value of 67.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with NGVT

Add Ingevity Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with NGVT